<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ultrasonographic scanning of carotid arteries allows non-invasive detection of atherosclerotic changes </plain></SENT>
<SENT sid="1" pm="."><plain>This technique has been used to investigate changes in the thickness of the intimal plus medial (IM) complex, in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and those in the <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> state of <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) </plain></SENT>
<SENT sid="2" pm="."><plain>IM thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) increases with age, but this process was found to be considerably accelerated in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was significantly greater in patients with cerebral <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarctions</z:e>, and in those with detectable <z:hpo ids='HP_0005145'>coronary artery stenosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A study in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> found that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> correlates with duration of <z:mp ids='MP_0002055'>diabetes</z:mp> as well as age </plain></SENT>
<SENT sid="5" pm="."><plain>The correlation with duration of <z:mp ids='MP_0002055'>diabetes</z:mp> suggests that <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> contributes to the progression of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was also found to be increased in individuals with hyperinsulinaemic IGT, compared with control individuals with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that even relatively small increases in postprandial blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels can lead to increases in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and, hence, increased risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Further analysis revealed a correlation between <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> (i.e. <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>) and increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These results provide a clear rationale for the therapeutic use of alpha-glucosidase inhibitors, such as <z:chebi fb="0" ids="2376">acarbose</z:chebi>, which attenuate postprandial <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>-induced <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> </plain></SENT>
</text></document>